Ideally, the technique of sampling tumor vascular segments from the pathophysiological environment would allow to microdissect immunohistochemically identified subsets of pericytes or endothelial cells that are differentially activated as observed by, for example, gain and loss of VEGFR2 and αvβ3. The gene discussed is KDR; the disease is neoplasm.